An interventional study of KF-STRIDE in Autism Spectrum Disorder, sponsored by Kessler Foundation. Recruiting at 1 site in United States. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-08-28.
Sponsored by Kessler Foundation · Not applicable, Interventional, and Treatment
Examine the acceptability, usability, feasibility, and initial efficacy of KF-STRIDE 3.0, the data from which will serve as a basis for a future fully powered RCT
Although KF-STRIDE 2.0 was designed to support youth on the spectrum, its current design may not be appropriate for adults. Thus, the current proposal will support development activities to significantly adapt KF-STRIDE 2.0 to meet the specific needs of adults with autism. As part of development, the investigators will partner with the autism community, using mixed methodology to ensure the investigators' modifications are performed with community-engaged methods. The investigators will invite adults with autism, family members, employers, and vocational counselors to provide feedback to guide the modifications to KF-STRIDE. The investigators will then test the acceptability, feasibility, fidelity, and initial efficacy of KF-STRIDE 3.0 among adults on the spectrum. Obtaining employment is essential to individuals on the spectrum as it can lead to improved community integration, increased social networking, and a means to contribute to society as productive citizens. Overall, the investigators propose to adapt a treatment that has strong potential to help adults with autism improve their job interview skills that will lead to increased employment.
1,724 studies on the registry are indexed under Autism Spectrum Disorder; 500 are open to participants now.
This study's planned enrollment of 30 is below the median of 52 across 1,368 interventional studies indexed under Autism Spectrum Disorder.
Browse Autism Spectrum Disorder studies →Kessler Foundation is the lead sponsor of 175 studies on the registry; 61 are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Behavioral: KF-STRIDE
KF Stride works to improve identification (awareness) of personal character strengths and 2) express them in a socially appropriate way during a job interview
20-minute long video-recorded Mock Job Interview, Autism Mock Interview Rating-Scale(A-MIRS)
Participants will choose 1 of 7 possible employment positions (i.e., security, childcare, culinary arts). Digital recordings will be scored by blinded raters with human resources expertise and trained to a reliable standard. Briefly, raters will rate videos using the Autism Mock Interview Rating-Scale (A-MIRS). The A-MIRS will rate the participant's 'likeliness to be hired' along with different interview skills (using a Likert-type scale 1=Poor to 7=Excellent). A total score will be evaluated, with higher scores indicating a higher likelihood to be hired. Maximum score of 77 and minimum score of 11. A higher score indicated better performance.
Time frame: Baseline, Immediate Post-Test between weeks 7 and 8
Work Readiness Scale
13 items about the perception of one's ability to work, with values ranging from 1 (strongly disagree) to 5(strongly agree), with higher scores indicating more work readiness. The maximum score is 65 and the minimum score is 13. A higher score indicates a better work readiness outcome.
Time frame: Baseline, Immediate Post-Test between weeks 7 and 8
Employment Status
The investigators will examine whether the participant became employed or other changes to employment status, (employment status, hours worked, wages earned, etc.) . Yes=1, No=0
Time frame: Baseline, Immediate Post-Test between weeks 7 and 8
World Health Organization Quality of Life abbreviated version (WHOQOL-BREF)
A self-report questionnaire which assesses 4 domains of quality of life (QOL): physical health, psychological health, social relationships, and environment. The range of scores is between 26 (minimum) and 130 (maximum). Higher scores indicate better quality of life.
Time frame: Baseline, Immediate Post-Test between weeks 7 and 8
Plan to share: No
No publications or documents are linked to this record.
Started Jan 2026 (actual). Primary completion is estimated for Jan 2027, 11 months after the start.
Of 800 non-industry interventional studies with no phase under Autism Spectrum Disorder, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 48. This study's planned 11 months is below that.
Counting every sponsor, half of 823 studies reached it within 25 months; a quarter within 12 and three quarters within 47.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.